0001415889-23-007888.txt : 20230512
0001415889-23-007888.hdr.sgml : 20230512
20230512160804
ACCESSION NUMBER: 0001415889-23-007888
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230511
FILED AS OF DATE: 20230512
DATE AS OF CHANGE: 20230512
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jacobson Allan Steven
CENTRAL INDEX KEY: 0001579003
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35969
FILM NUMBER: 23915700
MAIL ADDRESS:
STREET 1: PTC THERAPEUTICS, INC.
STREET 2: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001070081
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043416587
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
BUSINESS PHONE: 9082227000
MAIL ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
FORMER COMPANY:
FORMER CONFORMED NAME: PTC THERAPEUTICS INC
DATE OF NAME CHANGE: 19980909
4
1
form4-05122023_080552.xml
X0407
4
2023-05-11
0001070081
PTC THERAPEUTICS, INC.
PTCT
0001579003
Jacobson Allan Steven
C/O PTC THERAPEUTICS, INC.
100 CORPORATE COURT
SOUTH PLAINFIELD
NJ
07080
true
false
false
false
1
Common Stock
2023-05-11
4
M
0
23000
10.85
A
35348
D
Common Stock
2023-05-11
4
S
0
19040
54.7833
D
16308
D
Common Stock
2023-05-11
4
S
0
2860
56.3528
D
13448
D
Common Stock
2023-05-11
4
S
0
1100
56.9881
D
12348
D
Stock Option (Right to Buy)
10.85
2023-05-11
4
M
0
23000
10.85
D
2023-05-15
Common Stock
23000
0
D
Stock Option (Right to Buy)
27.05
2024-01-27
Common Stock
10000
10000
D
Stock Option (Right to Buy)
51
2025-01-01
Common Stock
12000
12000
D
Stock Option (Right to Buy)
30.86
2026-01-03
Common Stock
12000
12000
D
Stock Option (Right to Buy)
11.23
2027-01-02
Common Stock
12000
12000
D
Stock Option (Right to Buy)
18.01
2028-01-02
Common Stock
14000
14000
D
Stock Option (Right to Buy)
33.02
2029-01-21
Common Stock
14000
14000
D
Stock Option (Right to Buy)
51.16
2030-01-28
Common Stock
10000
10000
D
Stock Option (Right to Buy)
66.49
2031-01-05
Common Stock
10000
10000
D
Stock Option (Right to Buy)
38.10
2032-01-06
Common Stock
12000
12000
D
Stock Option (Right to Buy)
39.42
2033-01-04
Common Stock
10000
10000
D
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 11, 2022.
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $54.45 to $55.35 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $55.84 to $56.81 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $56.85 to $57.15 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Currently exercisable.
This option was granted on January 5, 2023 and vests over one year in twelve equal monthly installments, commencing on February 5, 2023.
/s/ Avraham S. Adler, Attorney-in-Fact
2023-05-12